Ogorek Anthony Joseph Gilead Sciences, Inc. Transaction History

Ogorek Anthony Joseph

$291 Million
Q3 2024

A detailed history of Ogorek Anthony Joseph transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ogorek Anthony Joseph holds 394 shares of GILD stock, worth $37,197. This represents 0.01% of its overall portfolio holdings.

Number of Shares

394

Previous 393 0.25%

Holding current value

$37,197

Previous $26,000 26.92%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$66.59 - $83.99 $66 - $83	1 Added 0.25%	394 $33,000
Q2 2024 Aug 08, 2024	SELL	$63.15 - $72.88 $16,103 - $18,584	-255 Reduced 39.35%	393 $26,000
Q1 2024 May 03, 2024	SELL	$71.58 - $87.29 $11,667 - $14,228	-163 Reduced 20.1%	648 $47,000
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $2.58 Million - $2.92 Million	-35,169 Reduced 97.75%	811 $65,000
Q3 2023 Oct 19, 2023	SELL	$73.94 - $80.67 $6,358 - $6,937	-86 Reduced 0.24%	35,980 $2.7 Million
Q2 2023 Aug 03, 2023	SELL	$76.01 - $86.7 $373,133 - $425,610	-4,909 Reduced 11.98%	36,066 $2.78 Million
Q1 2023 May 03, 2023	SELL	$77.31 - $88.08 $391,729 - $446,301	-5,067 Reduced 11.01%	40,975 $3.4 Million
Q4 2022 Jan 30, 2023	SELL	$62.32 - $89.47 $13,897 - $19,951	-223 Reduced 0.48%	46,042 $3.95 Million
Q3 2022 Oct 20, 2022	BUY	$59.54 - $68.01 $21,434 - $24,483	360 Added 0.78%	46,265 $2.85 Million
Q2 2022 Jul 21, 2022	BUY	$57.72 - $65.01 $68,455 - $77,101	1,186 Added 2.65%	45,905 $2.84 Million
Q1 2022 Apr 26, 2022	BUY	$57.92 - $72.58 $360,899 - $452,245	6,231 Added 16.19%	44,719 $2.66 Million
Q4 2021 Jan 18, 2022	BUY	$64.88 - $73.64 $1,686 - $1,914	26 Added 0.07%	38,488 $2.79 Million
Q3 2021 Oct 27, 2021	BUY	$67.69 - $73.03 $473 - $511	7 Added 0.02%	38,462 $2.69 Million
Q2 2021 Jul 14, 2021	BUY	$63.47 - $69.35 $66,008 - $72,124	1,040 Added 2.78%	38,455 $2.65 Million
Q1 2021 Apr 26, 2021	BUY	$60.0 - $68.46 $601,140 - $685,900	10,019 Added 36.57%	37,415 $2.42 Million
Q4 2020 Jan 20, 2021	BUY	$56.65 - $64.55 $51,551 - $58,740	910 Added 3.44%	27,396 $1.6 Million
Q3 2020 Nov 02, 2020	BUY	$62.1 - $78.08 $1.64 Million - $2.07 Million	26,486 New	26,486 $1.67 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ogorek Anthony Joseph , based on Form 13F filings with the SEC.

News

Stay updated on Ogorek Anthony Joseph with notifications on news.

Account

Ogorek Anthony Joseph Gilead Sciences, Inc. Transaction History